FAMILIAL ANOMALOUS BETA 2A-GLOBULIN. ACCOMPANIED BY DISORDERS OF BLOOD COAGULATION AND PATHOLOGIC IMMUNE PHENOMENA.
Published in Archives of internal medicine
AN EVALUATION OF THE ONE-STAGE FACTOR 8 ASSAY.
Published in Canadian journal of medical technology
TRANSFUSION OF BLOOD FRACTIONS.
Published in The Practitioner
VON WILLEBRAND'S DISEASE: USE OF A PLATELET-ADHESIVENESS TEST IN DIAGNOSIS AND FAMILY INVESTIGATION.
Published in The New England journal of medicine
SURGERY IN HAEMOPHILIA.
Published in The British journal of surgery
CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
Published in British medical journal
HEPARIN, PROTAMINE AND POLYBRENE. THEIR EFFECT UPON CERTAIN COAGULATION FACTORS AFTER INCUBATION WITH PLASMA.
Published in Thrombosis et diathesis haemorrhagica
INCREASE IN THE ACTIVITY OF COAGULATION FACTOR 8 IN CONNECTION WITH BRAIN SURGERY; PRELIMINARY STUDIES.
Published in Acta chirurgica Scandinavica
FURTHER EXPERIENCE IN USE OF HUMAN ANTIHAEMOPHILIC GLOBULIN (H.A.H.G.) FOR THE CONTROL OF BLEEDING AFTER DENTAL EXTRACTI...
Published in Lancet (London, England)
A CIRCULATING ANTICOAGULANT INHIBITING ANTIHAEMOPHILIC GLOBULIN.
Published in Journal of clinical pathology
A circulating anticoagulant inhibiting antihaemophilic globulin (A.H.G.) is described in an otherwise healthy 70-year-old woman, and the therapeutic response to steroids is discussed. The nature and pathogenesis of the anticoagulant remain obscure, but its properties and behaviour do not support an autoimmune aetiology.
